Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Journal
Age
Showing 1 to 12 of 1140 entries
Sorted by: Best Match Show Resources per page
NTP Toxicology and Carcinogenesis Studies of Oxazepam (CAS No. 604-75-1) in F344/N Rats (Feed Studies).

National Toxicology Program technical report series

[No authors listed]
PMID: 12579205
Natl Toxicol Program Tech Rep Ser. 1998 Oct;468:1-189.

Oxazepam and related benzodiazepine drugs are used in the treatment of anxiety. All benzodiazepines currently in use share a number of effects, including sedation, hypnosis, decreased anxiety, muscle relaxation, amnesia, and anticonvulsant activity. Oxazepam and four other benzodiazepines (chlordiazepoxide,...

Cite
NTP Toxicology and Carcinogenesis Studies of Oxazepam (CAS No. 604-75-1) in F344/N Rats (Feed Studies). Natl Toxicol Program Tech Rep Ser. 1998;468:1-189
(1998). NTP Toxicology and Carcinogenesis Studies of Oxazepam (CAS No. 604-75-1) in F344/N Rats (Feed Studies). National Toxicology Program technical report series, 4681-189.
"NTP Toxicology and Carcinogenesis Studies of Oxazepam (CAS No. 604-75-1) in F344/N Rats (Feed Studies)." National Toxicology Program technical report series vol. 468 (1998): 1-189.
NTP Toxicology and Carcinogenesis Studies of Oxazepam (CAS No. 604-75-1) in F344/N Rats (Feed Studies). Natl Toxicol Program Tech Rep Ser. 1998 Oct;468:1-189. PMID: 12579205.
Copy Download .nbib Format: NLM
Therapy of unspecific tinnitus without organic cause.

GMS health technology assessment

Frank W, Konta B, Seiler G.
PMID: 21289968
GMS Health Technol Assess. 2006 Aug 30;2:Doc17.

INTRODUCTION: There is a variety of medical and non-medical therapies in practice, which were not evaluated regarding its effectiveness by any systematic evidence oriented investigation. A number of therapies of medical and non-medical type try to treat the different...

Cite
Frank W, Konta B, Seiler G. Therapy of unspecific tinnitus without organic cause. GMS Health Technol Assess. 2006;2:Doc17
Frank, W., Konta, B., & Seiler, G. (2006). Therapy of unspecific tinnitus without organic cause. GMS health technology assessment, 2Doc17.
Frank, Wilhelm, et al. "Therapy of unspecific tinnitus without organic cause." GMS health technology assessment vol. 2 (2006): Doc17.
Frank W, Konta B, Seiler G. Therapy of unspecific tinnitus without organic cause. GMS Health Technol Assess. 2006 Aug 30;2:Doc17. PMID: 21289968; PMCID: PMC3011356.
Copy Download .nbib Format: NLM
Levels of Rat Brain mRna Encoding the Beta 1,2,3 and Gamma 2 Subunits of the Gaba-a Receptor Are Unchanged By Flurazepam Treatment: O'Donovan MC, Buckland PR and McGuffin P Dept. of Psychological Medicine, University of Wales College of Medicine, Heath Park, Cardiff, CF4 4XN.

Journal of psychopharmacology (Oxford, England)

[No authors listed]
PMID: 22291310
J Psychopharmacol. 1992 Jan;6(1):129. doi: 10.1177/026988119200600182.

No abstract available.

Cite
Levels of Rat Brain mRna Encoding the Beta 1,2,3 and Gamma 2 Subunits of the Gaba-a Receptor Are Unchanged By Flurazepam Treatment: O'Donovan MC, Buckland PR and McGuffin P Dept. of Psychological Medicine, University of Wales College of Medicine, Heath Park, Cardiff, CF4 4XN. J Psychopharmacol. 1992;6(1):129doi: 10.1177/026988119200600182.
(1992). Levels of Rat Brain mRna Encoding the Beta 1,2,3 and Gamma 2 Subunits of the Gaba-a Receptor Are Unchanged By Flurazepam Treatment: O'Donovan MC, Buckland PR and McGuffin P Dept. of Psychological Medicine, University of Wales College of Medicine, Heath Park, Cardiff, CF4 4XN. Journal of psychopharmacology (Oxford, England), 6(1), 129. https://doi.org/10.1177/026988119200600182
"Levels of Rat Brain mRna Encoding the Beta 1,2,3 and Gamma 2 Subunits of the Gaba-a Receptor Are Unchanged By Flurazepam Treatment: O'Donovan MC, Buckland PR and McGuffin P Dept. of Psychological Medicine, University of Wales College of Medicine, Heath Park, Cardiff, CF4 4XN." Journal of psychopharmacology (Oxford, England) vol. 6,1 (1992): 129. doi: https://doi.org/10.1177/026988119200600182
Levels of Rat Brain mRna Encoding the Beta 1,2,3 and Gamma 2 Subunits of the Gaba-a Receptor Are Unchanged By Flurazepam Treatment: O'Donovan MC, Buckland PR and McGuffin P Dept. of Psychological Medicine, University of Wales College of Medicine, Heath Park, Cardiff, CF4 4XN. J Psychopharmacol. 1992 Jan;6(1):129. doi: 10.1177/026988119200600182. PMID: 22291310.
Copy Download .nbib Format: NLM
Muscle relaxants for pain management in rheumatoid arthritis.

The Cochrane database of systematic reviews

Richards BL, Whittle SL, Buchbinder R.
PMID: 22258993
Cochrane Database Syst Rev. 2012 Jan 18;1:CD008922. doi: 10.1002/14651858.CD008922.pub2.

BACKGROUND: Pain management is a high priority for patients with rheumatoid arthritis (RA). Muscle relaxants include drugs that reduce muscle spasm (for example benzodiazepines such as diazepam (Valium), alprazolam (Xanax), lorazepam (Ativan) and non-benzodiazepines such as metaxalone (Skelaxin) or...

Cite
Richards BL, Whittle SL, Buchbinder R. Muscle relaxants for pain management in rheumatoid arthritis. Cochrane Database Syst Rev. 2012;1:CD008922doi: 10.1002/14651858.CD008922.pub2.
Richards, B. L., Whittle, S. L., & Buchbinder, R. (2012). Muscle relaxants for pain management in rheumatoid arthritis. The Cochrane database of systematic reviews, 1CD008922. https://doi.org/10.1002/14651858.CD008922.pub2
Richards, Bethan L, et al. "Muscle relaxants for pain management in rheumatoid arthritis." The Cochrane database of systematic reviews vol. 1 (2012): CD008922. doi: https://doi.org/10.1002/14651858.CD008922.pub2
Richards BL, Whittle SL, Buchbinder R. Muscle relaxants for pain management in rheumatoid arthritis. Cochrane Database Syst Rev. 2012 Jan 18;1:CD008922. doi: 10.1002/14651858.CD008922.pub2. PMID: 22258993.
Copy Download .nbib Format: NLM
Effects of benzodiazepines, antidepressants and opioids on driving: a systematic review and meta-analysis of epidemiological and experimental evidence.

Drug safety

Dassanayake T, Michie P, Carter G, Jones A.
PMID: 21247221
Drug Saf. 2011 Feb 01;34(2):125-56. doi: 10.2165/11539050-000000000-00000.

BACKGROUND: Many individuals in the community are prescribed psychoactive drugs with sedative effects. These drugs may affect their daily functions, of which automobile driving is a major component.OBJECTIVE: To examine the association of three classes of commonly used psychoactive...

Cite
Dassanayake T, Michie P, Carter G, et al. Effects of benzodiazepines, antidepressants and opioids on driving: a systematic review and meta-analysis of epidemiological and experimental evidence. Drug Saf. 2011;34(2):125-56doi: 10.2165/11539050-000000000-00000.
Dassanayake, T., Michie, P., Carter, G., & Jones, A. (2011). Effects of benzodiazepines, antidepressants and opioids on driving: a systematic review and meta-analysis of epidemiological and experimental evidence. Drug safety, 34(2), 125-56. https://doi.org/10.2165/11539050-000000000-00000
Dassanayake, Tharaka, et al. "Effects of benzodiazepines, antidepressants and opioids on driving: a systematic review and meta-analysis of epidemiological and experimental evidence." Drug safety vol. 34,2 (2011): 125-56. doi: https://doi.org/10.2165/11539050-000000000-00000
Dassanayake T, Michie P, Carter G, Jones A. Effects of benzodiazepines, antidepressants and opioids on driving: a systematic review and meta-analysis of epidemiological and experimental evidence. Drug Saf. 2011 Feb 01;34(2):125-56. doi: 10.2165/11539050-000000000-00000. PMID: 21247221.
Copy Download .nbib Format: NLM
Role of giant depolarizing potentials in shaping synaptic currents in the developing hippocampus.

Critical reviews in neurobiology

Mohajerani MH, Cherubini E.
PMID: 17725505
Crit Rev Neurobiol. 2006;18(1):13-23. doi: 10.1615/critrevneurobiol.v18.i1-2.30.

Early in development, network activity in the hippocampus is characterized by giant depolarizing potentials (GDPs). These potentials consist of recurrent membrane depolarizations with superimposed fast action potentials separated by quiescent intervals. They are generated by the interplay of glutamate...

Cite
Mohajerani MH, Cherubini E. Role of giant depolarizing potentials in shaping synaptic currents in the developing hippocampus. Crit Rev Neurobiol. 2006;18(1):13-23doi: 10.1615/critrevneurobiol.v18.i1-2.30.
Mohajerani, M. H., & Cherubini, E. (2006). Role of giant depolarizing potentials in shaping synaptic currents in the developing hippocampus. Critical reviews in neurobiology, 18(1), 13-23. https://doi.org/10.1615/critrevneurobiol.v18.i1-2.30
Mohajerani, Majid H, and Cherubini, Enrico. "Role of giant depolarizing potentials in shaping synaptic currents in the developing hippocampus." Critical reviews in neurobiology vol. 18,1 (2006): 13-23. doi: https://doi.org/10.1615/critrevneurobiol.v18.i1-2.30
Mohajerani MH, Cherubini E. Role of giant depolarizing potentials in shaping synaptic currents in the developing hippocampus. Crit Rev Neurobiol. 2006;18(1):13-23. doi: 10.1615/critrevneurobiol.v18.i1-2.30. PMID: 17725505.
Copy Download .nbib Format: NLM
Pharmacological properties of GABAA receptors containing gamma1 subunits.

Molecular pharmacology

Khom S, Baburin I, Timin EN, Hohaus A, Sieghart W, Hering S.
PMID: 16272224
Mol Pharmacol. 2006 Feb;69(2):640-9. doi: 10.1124/mol.105.017236. Epub 2005 Nov 04.

GABA(A) receptors composed of alpha(1), beta(2), gamma(1) subunits are expressed in only a few areas of the brain and thus represent interesting drug targets. The pharmacological properties of this receptor subtype, however, are largely unknown. In the present study,...

Cite
Khom S, Baburin I, Timin EN, et al. Pharmacological properties of GABAA receptors containing gamma1 subunits. Mol Pharmacol. 2005;69(2):640-9doi: 10.1124/mol.105.017236.
Khom, S., Baburin, I., Timin, E. N., Hohaus, A., Sieghart, W., & Hering, S. (2006). Pharmacological properties of GABAA receptors containing gamma1 subunits. Molecular pharmacology, 69(2), 640-9. https://doi.org/10.1124/mol.105.017236
Khom, S, et al. "Pharmacological properties of GABAA receptors containing gamma1 subunits." Molecular pharmacology vol. 69,2 (2006): 640-9. doi: https://doi.org/10.1124/mol.105.017236
Khom S, Baburin I, Timin EN, Hohaus A, Sieghart W, Hering S. Pharmacological properties of GABAA receptors containing gamma1 subunits. Mol Pharmacol. 2006 Feb;69(2):640-9. doi: 10.1124/mol.105.017236. Epub 2005 Nov 04. PMID: 16272224.
Copy Download .nbib Format: NLM
Review of Safety and Efficacy of Sleep Medicines in Older Adults.

Clinical therapeutics

Schroeck JL, Ford J, Conway EL, Kurtzhalts KE, Gee ME, Vollmer KA, Mergenhagen KA.
PMID: 27751669
Clin Ther. 2016 Nov;38(11):2340-2372. doi: 10.1016/j.clinthera.2016.09.010. Epub 2016 Oct 15.

PURPOSE: Insomnia is problematic for older adults. After behavioral modifications fail to show adequate response, pharmacologic options are used. The pharmacokinetics of agents used to treat insomnia may be altered. This review focuses on the safety and efficacy of...

Cite
Schroeck JL, Ford J, Conway EL, et al. Review of Safety and Efficacy of Sleep Medicines in Older Adults. Clin Ther. 2016;38(11):2340-2372doi: 10.1016/j.clinthera.2016.09.010.
Schroeck, J. L., Ford, J., Conway, E. L., Kurtzhalts, K. E., Gee, M. E., Vollmer, K. A., & Mergenhagen, K. A. (2016). Review of Safety and Efficacy of Sleep Medicines in Older Adults. Clinical therapeutics, 38(11), 2340-2372. https://doi.org/10.1016/j.clinthera.2016.09.010
Schroeck, Jennifer L, et al. "Review of Safety and Efficacy of Sleep Medicines in Older Adults." Clinical therapeutics vol. 38,11 (2016): 2340-2372. doi: https://doi.org/10.1016/j.clinthera.2016.09.010
Schroeck JL, Ford J, Conway EL, Kurtzhalts KE, Gee ME, Vollmer KA, Mergenhagen KA. Review of Safety and Efficacy of Sleep Medicines in Older Adults. Clin Ther. 2016 Nov;38(11):2340-2372. doi: 10.1016/j.clinthera.2016.09.010. Epub 2016 Oct 15. PMID: 27751669.
Copy Download .nbib Format: NLM
Benzodiazepines and synaptic processing in the spatial domain within the cat's primary somatosensory cortex.

Canadian journal of physiology and pharmacology

Oka JI, Hicks TP.
PMID: 1975221
Can J Physiol Pharmacol. 1990 Aug;68(8):1025-40. doi: 10.1139/y90-156.

In the primary somatosensory cortex of cats, the size of the receptive fields (RFs) of cutaneously responsive neurones is under the control of gamma-aminobutyric acid (GABA) mediated inhibition when the cells are situated in rapidly adapting (RA) background regions....

Cite
Oka JI, Hicks TP. Benzodiazepines and synaptic processing in the spatial domain within the cat's primary somatosensory cortex. Can J Physiol Pharmacol. 1990;68(8):1025-40doi: 10.1139/y90-156.
Oka, J. I., & Hicks, T. P. (1990). Benzodiazepines and synaptic processing in the spatial domain within the cat's primary somatosensory cortex. Canadian journal of physiology and pharmacology, 68(8), 1025-40. https://doi.org/10.1139/y90-156
Oka, J I, and Hicks, T P. "Benzodiazepines and synaptic processing in the spatial domain within the cat's primary somatosensory cortex." Canadian journal of physiology and pharmacology vol. 68,8 (1990): 1025-40. doi: https://doi.org/10.1139/y90-156
Oka JI, Hicks TP. Benzodiazepines and synaptic processing in the spatial domain within the cat's primary somatosensory cortex. Can J Physiol Pharmacol. 1990 Aug;68(8):1025-40. doi: 10.1139/y90-156. PMID: 1975221.
Copy Download .nbib Format: NLM
Benzodiazepines inhibit thyrotropin (TSH)-releasing hormone-induced TSH and growth hormone release from perifused rat pituitaries.

Endocrinology

Roussel JP, Astier H, Tapia-Arancibia L.
PMID: 3023014
Endocrinology. 1986 Dec;119(6):2519-26. doi: 10.1210/endo-119-6-2519.

The perifusion technique was used to investigate the action of diazepam (DZ), a benzodiazepine molecule known to compete for TRH receptor binding in rat pituitary, on TRH-induced TSH and GH release. The release kinetics for the two hormones from...

Cite
Roussel JP, Astier H, Tapia-Arancibia L. Benzodiazepines inhibit thyrotropin (TSH)-releasing hormone-induced TSH and growth hormone release from perifused rat pituitaries. Endocrinology. 1986;119(6):2519-26doi: 10.1210/endo-119-6-2519.
Roussel, J. P., Astier, H., & Tapia-Arancibia, L. (1986). Benzodiazepines inhibit thyrotropin (TSH)-releasing hormone-induced TSH and growth hormone release from perifused rat pituitaries. Endocrinology, 119(6), 2519-26. https://doi.org/10.1210/endo-119-6-2519
Roussel, J P, et al. "Benzodiazepines inhibit thyrotropin (TSH)-releasing hormone-induced TSH and growth hormone release from perifused rat pituitaries." Endocrinology vol. 119,6 (1986): 2519-26. doi: https://doi.org/10.1210/endo-119-6-2519
Roussel JP, Astier H, Tapia-Arancibia L. Benzodiazepines inhibit thyrotropin (TSH)-releasing hormone-induced TSH and growth hormone release from perifused rat pituitaries. Endocrinology. 1986 Dec;119(6):2519-26. doi: 10.1210/endo-119-6-2519. PMID: 3023014.
Copy Download .nbib Format: NLM
Site-specific enhancement of gamma-aminobutyric acid-mediated inhibition of neural activity by ethanol in the rat medial septal area.

The Journal of pharmacology and experimental therapeutics

Givens BS, Breese GR.
PMID: 2166794
J Pharmacol Exp Ther. 1990 Aug;254(2):528-38.
Free PMC Article

Because of uncertainty concerning the interaction of ethanol with gamma-aminobutyric acid (GABA) receptor-mediated events, the present work was designed to investigate the effect of ethanol on GABA transmission in the rat septal area using behavioral and electrophysiological techniques. Microinjection...

Cite
Givens BS, Breese GR. Site-specific enhancement of gamma-aminobutyric acid-mediated inhibition of neural activity by ethanol in the rat medial septal area. J Pharmacol Exp Ther. 1990;254(2):528-38
Givens, B. S., & Breese, G. R. (1990). Site-specific enhancement of gamma-aminobutyric acid-mediated inhibition of neural activity by ethanol in the rat medial septal area. The Journal of pharmacology and experimental therapeutics, 254(2), 528-38.
Givens, B S, and Breese, G R. "Site-specific enhancement of gamma-aminobutyric acid-mediated inhibition of neural activity by ethanol in the rat medial septal area." The Journal of pharmacology and experimental therapeutics vol. 254,2 (1990): 528-38.
Givens BS, Breese GR. Site-specific enhancement of gamma-aminobutyric acid-mediated inhibition of neural activity by ethanol in the rat medial septal area. J Pharmacol Exp Ther. 1990 Aug;254(2):528-38. PMID: 2166794; PMCID: PMC3010747.
Copy Download .nbib Format: NLM
Positive allosteric activation of GABAA receptors bi-directionally modulates hippocampal glutamate plasticity and behaviour.

Biochemical Society transactions

Shen G, Mohamed MS, Das P, Tietz EI.
PMID: 19909283
Biochem Soc Trans. 2009 Dec;37:1394-8. doi: 10.1042/BST0371394.

Long-term BZ (benzodiazepine) anxiolytic therapy increases the risk of physical dependence manifested as withdrawal anxiety. BZ-induced potentiation of GABA(A)R (gamma-aminobutyric acid type-A receptor) function by 1-week oral administration of FZP (flurazepam) bi-directionally modulates excitatory glutamatergic synaptic transmission in hippocampal...

Cite
Shen G, Mohamed MS, Das P, et al. Positive allosteric activation of GABAA receptors bi-directionally modulates hippocampal glutamate plasticity and behaviour. Biochem Soc Trans. 2009;37:1394-8doi: 10.1042/BST0371394.
Shen, G., Mohamed, M. S., Das, P., & Tietz, E. I. (2009). Positive allosteric activation of GABAA receptors bi-directionally modulates hippocampal glutamate plasticity and behaviour. Biochemical Society transactions, 371394-8. https://doi.org/10.1042/BST0371394
Shen, Guofu, et al. "Positive allosteric activation of GABAA receptors bi-directionally modulates hippocampal glutamate plasticity and behaviour." Biochemical Society transactions vol. 37 (2009): 1394-8. doi: https://doi.org/10.1042/BST0371394
Shen G, Mohamed MS, Das P, Tietz EI. Positive allosteric activation of GABAA receptors bi-directionally modulates hippocampal glutamate plasticity and behaviour. Biochem Soc Trans. 2009 Dec;37:1394-8. doi: 10.1042/BST0371394. PMID: 19909283.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 1140 entries